Dan Ouyang has represented corporate clients across a variety of industries, including technology, healthcare, education, and entertainment in over 100 IPOs and follow-on offerings in the U.S. and Hong Kong.
She was also previously a journalist at China Central Television and China Radio International. Dan Ouyang represented WuXi XDC in its spin-off from Wuxi Biologics and its HK$4.07 billion Hong Kong IPO and listing, as well as Tencent in Tencent Music’s U.S. IPO.
Contact: douyang@wsgr.com